NCT06565611Phase 2Active not recruiting

A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity

Study sponsor: Palatin Technologies, Inc · PTN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-02-05Actual
Enrollment · participants108Estimated
Source updated2025-03-06Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview